Hydroquinone increases 5-hydroxymethylcytosine formation through ten eleven translocation 1 (TET1) 5-methylcytosine dioxygenase

Journal of Biological Chemistry

Volumn 288, Issue 40, 2013, Pages 28792-28800

  Coulter, Jonathan B ^a   O'Driscoll, Cliona M ^a   Bressler, Joseph P ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5-HYDROXYMETHYLCYTOSINE; DIOXYGENASES; DNA DEMETHYLATION; DNA METHYLATION; METHYLCYTOSINE;

BENZENE;

PHENOLS;

5 HYDROXYMETHYLCYTOSINE; ACETYLCYSTEINE; DIOXYGENASE; DNA; GLUTAMATE CYSTEINE LIGASE; GLUTAMATE CYSTEINE LIGASE CATALYTIC SUBUNIT; HYDROQUINONE; PROTEIN 14 3 3; REACTIVE OXYGEN METABOLITE; TEN ELEVEN TRANSLOCATION 1 5 METHYLCYTOSINE DIOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA METHYLATION; DRUG MECHANISM; ENZYME BINDING; ENZYME INDUCTION; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REPORTER GENE; SIGNAL TRANSDUCTION;

BENZENE; DIOXYGENASE; DNA DEMETHYLATION; DNA METHYLATION; EPIGENETICS; HYDROQUINONE; QUINONES; REACTIVE OXYGEN SPECIES (ROS); TEN ELEVEN TRANSLOCATION 1; TET1;

CELL CYCLE; CELL NUCLEUS; CYTOSINE; DIOXYGENASES; DNA; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENOME, HUMAN; HEK293 CELLS; HUMANS; HYDROQUINONES; PROTO-ONCOGENE PROTEINS; REACTIVE OXYGEN SPECIES;

EID: 84885130071     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.491365     Document Type: Article

References (37)

1. Jaenisch, R., and Bird, A. (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245-254
2. Tsai, H. C., and Baylin, S. B. (2011) Cancer epigenetics: linking basic biology to clinical medicine. Cell Res. 21, 502-517
3. Millan, M. J. (2013) An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology 68, 2-82
4. Ishida, K., Kobayashi, T., Ito, S., Komatsu, Y., Yokoyama, T., Okada, M., Abe, A., Murasawa, A., and Yoshie, H. (2012) Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis. J. Periodontol. 83, 917-925
5. Ponferrada-Marín, M. I., Martínez-Macías, M. I., Morales-Ruiz, T., Roldán-Arjona, T., and Ariza, R. R. (2010) Methylation-independentDNA binding modulates specificity of repressor of silencing 1 (ROS1) and facilitates demethylation in long substrates. J. Biol. Chem. 285, 23032-23039
6. Christman, J. K. (2002) 5-Azacytidine and 5-aza-2-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483-5495
7. Guo, J. U., Ma, D. K., Mo, H., Ball, M. P., Jang, M. H., Bonaguidi, M. A., Balazer, J. A., Eaves, H. L., Xie, B., Ford, E., Zhang, K., Ming, G. L., Gao, Y., and Song, H. (2011) Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat. Neurosci. 14, 1345-1351
8. O'Driscoll, C. M., Coulter, J. B., and Bressler, J. P. (2013) Induction of a trophoblast-like phenotype by hydralazine in the P19 embryonic carcinoma cell line. Biochim. Biophys. Acta 1833, 460-467
9. Bollati, V., Baccarelli, A., Hou, L., Bonzini, M., Fustinoni, S., Cavallo, D., Byun, H. M., Jiang, J., Marinelli, B., Pesatori, A. C., Bertazzi, P. A., and Yang, A. S. (2007) Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67, 876-880
10. Lee, B. H., Yegnasubramanian, S., Lin, X., and Nelson, W. G. (2005) Procainamide is a specific inhibitor ofDNAmethyltransferase 1. J. Biol. Chem. 280, 40749-40756
11. Lee, W. J., and Zhu, B. T. (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27, 269-277
12. Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., and Rao, A. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935
13. Ito, S., D'Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., and Zhang, Y. (2010) Role of TET proteins in 5mC to 5hmC conversion, EScell self-renewal and inner cell mass specification. Nature 466, 1129-1133
14. Guo, J. U., Su, Y., Zhong, C., Ming, G. L., and Song, H. (2011) Hydroxylation of 5-methylcytosine by TET1 promotes activeDNAdemethylation in the adult brain. Cell 145, 423-434
15. Ong, C. N., Lee, B. L., Shi, C. Y., Ong, H. Y., and Lee, H. P. (1994) Elevated levels of benzene-related compounds in the urine of cigarette smokers. Int. J. Cancer 59, 177-180
16. International Agency for Research on Cancer (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to IARC Monogr. Eval. Carcinog. Risks Hum. Suppl. 7, 1-440
17. Parke, D. V., and Williams, R. T. (1953) The metabolism of benzene containing C14 benzene. Biochem. J. 54, 231-238
18. Snyder, R., and Hedli, C. C. (1996) An overview of benzene metabolism. Environ. Health Perspect. 104, 1165-1171
19. Kolachana, P., Subrahmanyam, V. V., Meyer, K. B., Zhang, L., and Smith, M. T. (1993) Benzene and its phenolic metabolites produce oxidative DNAdamage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 53, 1023-1026
20. Shen, D. X., Shi, X., Fu, J. L., Zhang, Y. M., and Zhou, Z. C. (2003) The role of thiol reduction in hydroquinone-induced apoptosis in HEK293 cells. Chem. Biol. Interact. 145, 225-233
21. Parmentier, R., and Dustin, P., Jr. (1948) Early effects of hydroquinone on mitosis. Nature 161, 527
22. Ji, Z., Zhang, L., Peng, V., Ren, X., McHale, C. M., and Smith, M. T. (2010) A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide. Leukemia 24, 986-991
23. Muotri, A. R., Marchetto, M. C., Coufal, N. G., Oefner, R., Yeo, G., Nakashima, K., and Gage, F. H. (2010) L1 retrotransposition in neurons is modulated by MeCP2. Nature 468, 443-446
24. Westfall, M. D., Mays, D. J., Sniezek, J. C., and Pietenpol, J. A. (2003) The Np63 phosphoprotein binds the p21 and 14-3-3 promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 23, 2264-2276
25. Du, W., Rani, R., Sipple, J., Schick, J., Myers, K. C., Mehta, P., Andreassen, P. R., Davies, S. M., and Pang, Q. (2012) The FA pathway counteracts oxidative stress through protection of antioxidant defense gene promoters. Blood 119, 4142-4151
26. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., Funke, R., Gage, D., Harris, K., Heaford, A., Howland, J., Kann, L., Lehoczky, J., LeVine, R., McEwan, P., McKernan, K., Meldrim, J., Mesirov, J. P., Miranda, C., Morris, W., Naylor, J., Raymond, C., Rosetti, M., Santos, R., Sheridan, A., Sougnez, C., Stange-Thomann, N., Stojanovic, N., Subramanian, A., Wyman, D., Rogers, J., Sulston, J., Ainscough, R., Beck, S., Bentley, D., Burton, J., Clee, C., Carter, N., Coulson, A., Deadman, R., Deloukas, P., Dunham, A., Dunham, I., Durbin, R., French, L., Grafham, D., and Gregory, S. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921
27. Hermeking, H., Lengauer, C., Polyak, K., He, T. C., Zhang, L., Thiagalingam, S., Kinzler, K. W., and Vogelstein, B. (1997) 14-3-3 is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3-11
28. Lodygin, D., and Hermeking, H. (2005) The role of epigenetic inactivation of 14-3-3 in human cancer. Cell Res. 15, 237-246
29. Ferguson, A. T., Evron, E., Umbricht, C. B., Pandita, T. K., Chan, T. A., Hermeking, H., Marks, J. R., Lambers, A. R., Futreal, P. A., Stampfer, M. R., and Sukumar, S. (2000) High frequency of hypermethylation at the 14-3-3 locus leads to gene silencing in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 97, 6049-6054
30. Yi, B., Tan, S. X., Tang, C. E., Huang, W. G., Cheng, A. L., Li, C., Zhang, P. F., Li, M. Y., Li, J. L, Yi, H., Peng, F., Chen, Z. C., and Xiao, Z. Q. (2009) Inactivation of 14-3-3 by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. J. Cell. Biochem. 106, 858-866
31. O'Hagan, H. M., Wang, W., Sen, S., Destefano Shields, C., Lee, S. S., Zhang, Y. W., Clements, E. G., Cai, Y., Van Neste, L., Easwaran, H., Casero, R. A., Sears, C. L., and Baylin, S. B. (2011) Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG islands. Cancer Cell 20, 606-619
32. Lertratanangkoon, K., Wu, C. J., Savaraj, N., and Thomas, M. L. (1997) Alterations of DNA methylation by glutathione depletion. Cancer Lett. 120, 149-156
33. Cerda, S., and Weitzman, S. A. (1997) Influence of oxygen radical injury on DNA methylation. Mutat. Res. 386, 141-152
34. Castro, G. D., Díaz Gómez, M. I., and Castro, J. A. (1996) 5-Methylcytosine attack by hydroxyl free radicals and during carbon tetrachloride promoted liver microsomal lipid peroxidation: structure of reaction products. Chem. Biol. Interact. 99, 289-299
35. Wagner, J. R., and Cadet, J. (2010) Oxidation reactions of cytosine DNA components by hydroxyl radical and one-electron oxidants in aerated aqueous solutions. Acc. Chem. Res. 43, 564-571
36. Orr, B. A., Haffner, M. C., Nelson, W. G., Yegnasubramanian, S., and Eberhart, C. G. (2012) Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma. PLoS One 7, e41036
37. Liu, C., Liu, L., Chen, X., Shen, J., Shan, J., Xu, Y., Yang, Z., Wu, L., Xia, F., Bie, P., Cui, Y., Bian, X. W., and Qian, C. (2013) Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through down-regulation of TET1. PLoS One 8, e62828